Literature DB >> 1525042

Cloning and regulation by glucocorticoid receptor ligands of a rat hsp90.

J A McGuire1, L Poellinger, A C Wikström, J A Gustafsson.   

Abstract

We have isolated a full length cDNA that encodes a heat shock protein, hsp90, from a rat brain library and present the nucleotide sequence and deduced amino acid sequence. Comparison of the entire nucleotide sequence with mouse hsp84 and human hsp90 beta cDNAs reveal sequence similarities of 92 and 87%, respectively. The coding region of 2172 nucleotides corresponds to a polypeptide chain of 724 amino acids. Comparison with mouse hsp84 and human hsp90 beta amino acid sequences indicates a similarity of 97%, respectively. Characterization of the constitutive expression of this cDNA both by RNA blot hybridization and immunoblotting, reveals that it is expressed in all rat tissues examined. Hsp90 has been shown to form a transient complex with steroid hormone receptors. In order to further elucidate the role of hsp90 in the endocrine response of cells, we have examined the effects of dexamethasone and RU38486 on the level of hsp90 mRNA in a system in which glucocorticoids down-regulate glucocorticoid receptor mRNA levels. In this system, a subtle but reproducible approx. 2-fold decrease in hsp90 mRNA levels is observed after 48 h treatment with dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525042     DOI: 10.1016/0960-0760(92)90089-2

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

Review 1.  Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system.

Authors:  J P Herman
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

2.  Cell density modulates growth, extracellular matrix, and protein synthesis of cultured rat mesangial cells.

Authors:  A Wolthuis; A Boes; J Grond
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids.

Authors:  A Holownia; R M Mroz; A Kielek; E Chyczewska; J J Braszko
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.